FGL2 and chronic kidney disease: In this study, we found that a higher FGL2 mRNA expression level in kidney biopsies of CKD patients was associated with lower eGFR and higher tubulointerstitial fibrosis at baseline as well as progression of CKD during the longitudinal observation period.